Baxter Oncology is an API and finished-dose manufacturer based in Germany. It holds one active US drug master file. Its filings concentrate with EDE (AE), ARCSA (EC) and INVIMA (CO). Its GMP standing is certified by ZLG (DE), NCELS (KZ) and MFDS (Korea).
| Site | FDA FEI |
|---|---|
| Halle/Westfalen, United Arab Emirates | Not on file |
| Halle (Westf), Germany | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Cyclophosphamide | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EDE (AE) | 481 | None |
| ARCSA (EC) | 16 | None |
| INVIMA (CO) | 10 | None |
| DPM (TN) | 7 | None |
| EDA (EG) | 7 | None |
| ANPP (DZ) | 3 | None |
| ZLG (DE) | None | 4 |
| NCELS (KZ) | None | 2 |
| MFDS (Korea) | None | 2 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Baxter Oncology, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.